This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Wyeth, American Home Products Corporation. Active years: 2001-2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001-2002
Title: John C. Clark: Innovating Extended Release Formulations
Introduction
John C. Clark is an accomplished inventor based in Peru, NY, known for his significant contributions to the field of pharmaceuticals. With a total of three patents to his name, he has made remarkable advancements in medication formulations, particularly in enhancing the effectiveness of antidepressants.
Latest Patents
One of John C. Clark's most notable inventions is the extended release formulation of venlafaxine hydrochloride. This invention pertains to a 24-hour extended release dosage formulation of venlafaxine hydrochloride, an antidepressant. The formulation is designed to provide superior control of blood plasma levels compared to conventional tablet forms, which typically require multiple daily doses. Additionally, Clark's invention helps reduce the incidence of nausea and vomiting commonly associated with traditional tablet formulations. This innovative approach comprises an extended release formulation of venlafaxine hydrochloride using spheroids that include microcrystalline cellulose and, optionally, hydroxypropylmethylcellulose, all coated with a mixture of ethyl cellulose and hydroxypropylmethylcellulose.
Career Highlights
Throughout his career, John C. Clark has worked with notable companies, including Wyeth and American Home Products Corporation. His contributions have significantly impacted the pharmaceutical industry, particularly in improving patient compliance and comfort through better medication delivery systems.
Collaborations
In his professional journey, John has collaborated with esteemed colleagues such as Deborah M. Sherman and John U. Lamer. These collaborations have undoubtedly enriched his work and contributed to the successful development of his patented innovations.
Conclusion
John C. Clark stands out as a pioneering inventor in the realm of pharmaceutical formulations. His innovative work on the extended release formulation of venlafaxine hydrochloride not only enhances treatment efficacy but also improves patient quality of life. As he continues to contribute to the field of medicine, his influence on future pharmaceutical innovations is anticipated to be profound.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile